Literature DB >> 18021900

Innate immunity and antimicrobial defense systems in psoriasis.

Amanda S Büchau1, Richard L Gallo.   

Abstract

Psoriasis is a chronic inflammatory disorder that is mediated by elements of the innate and adaptive immune systems. Its characteristic features in the skin consist of inflammatory changes in both dermis and epidermis, with abnormal keratinocyte differentiation and proliferation. Despite the elucidation of many aspects of psoriasis pathogenesis, some puzzling questions remain to be answered. A major question currently debated is whether psoriasis is a primary abnormality of the epidermal keratinocyte or a reflection of dysregulated bone marrow-derived immunocytes. In this review we will focus on understanding the role of the innate immune system in psoriasis and how this provides a rational solution to address the origin of this multifactorial disease. Innate immunity is nonspecific and genetically based. It protects the body against the constant risk of pathogens through the use of rapidly mobilized defenses that are able to recognize and kill a variety of threats (bacteria, fungi, viruses, etc). The key mechanisms of innate immune responses are the existence of receptors to recognize pathogens and the production of factors that kill pathogens, such as antimicrobial peptides and proteins. Any combination of excessive sensitivity of the innate detection system, or dysregulation of the response system, can manifest both an epidermal phenotype and an abnormal T-cell function. Thus, the multidimensional action of the innate immune system, its triggers, and its recently understood role in T-cell function argue for an important role for innate mechanisms of recognition and response in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021900      PMCID: PMC2699547          DOI: 10.1016/j.clindermatol.2007.08.016

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  92 in total

Review 1.  The immunologic basis for the treatment of psoriasis with new biologic agents.

Authors:  James G Krueger
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

2.  Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis.

Authors:  Peck Y Ong; Qutayba A Hamid; Jeffrey B Travers; Ian Strickland; Muhamed Al Kerithy; Mark Boguniewicz; Donald Y M Leung
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation.

Authors:  Alice Y Liu; Delphine Destoumieux; Annie V Wong; Christina H Park; Erika V Valore; Lide Liu; Tomas Ganz
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

4.  Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees.

Authors:  Sabrina Semprini; Francesca Capon; Alessandra Tacconelli; Emiliano Giardina; Angela Orecchia; Rita Mingarelli; Tommaso Gobello; Giovanna Zambruno; Annalisa Botta; Giuseppe Fabrizi; Giuseppe Novelli
Journal:  Hum Genet       Date:  2002-08-21       Impact factor: 4.132

5.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

6.  Paneth cell trypsin is the processing enzyme for human defensin-5.

Authors:  Dipankar Ghosh; Edith Porter; Bo Shen; Sarah K Lee; Dennis Wilk; Judith Drazba; Satya P Yadav; John W Crabb; Tomas Ganz; Charles L Bevins
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

7.  Expression of functional Toll-like receptor 2 on human epidermal keratinocytes.

Authors:  Kazuhiro Kawai; Hideki Shimura; Masahiro Minagawa; Akiko Ito; Katsuhiro Tomiyama; Masaaki Ito
Journal:  J Dermatol Sci       Date:  2002-12       Impact factor: 4.563

8.  The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris.

Authors:  N Kanda; K Tani; U Enomoto; K Nakai; S Watanabe
Journal:  Clin Exp Allergy       Date:  2002-08       Impact factor: 5.018

9.  Human keratinocytes express functional CD14 and toll-like receptor 4.

Authors:  Peter I Song; Young-Min Park; Tonya Abraham; Brad Harten; Adam Zivony; Natalia Neparidze; Cheryl A Armstrong; John C Ansel
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

10.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  38 in total

1.  Identification of cell types, tissues and pathways affected by risk loci in psoriasis.

Authors:  Yan Lin; Pan Zhao; Changbing Shen; Songke Shen; Xiaodong Zheng; Xianbo Zuo; Sen Yang; Xuejun Zhang; Xianyong Yin
Journal:  Mol Genet Genomics       Date:  2015-11-12       Impact factor: 3.291

2.  M1 and M2 Macrophages Polarization via mTORC1 Influences Innate Immunity and Outcome of Ehrlichia Infection.

Authors:  Ibrahim Ahmed; Nahed Ismail
Journal:  J Cell Immunol       Date:  2020

Review 3.  Application of angiogenesis to clinical dermatology.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Adv Dermatol       Date:  2008

4.  Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis.

Authors:  Ute Laggner; Paola Di Meglio; Gayathri K Perera; Christian Hundhausen; Katie E Lacy; Niwa Ali; Catherine H Smith; Adrian C Hayday; Brian J Nickoloff; Frank O Nestle
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

5.  Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.

Authors:  Ilona Kryczek; Allen T Bruce; Johann E Gudjonsson; Andrew Johnston; Abhishek Aphale; Linhua Vatan; Wojciech Szeliga; Yin Wang; Yan Liu; Theodore H Welling; James T Elder; Weiping Zou
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models.

Authors:  Johann E Gudjonsson; Jun Ding; Andrew Johnston; Trilokraj Tejasvi; Andrew M Guzman; Rajan P Nair; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2010-03-11       Impact factor: 8.551

7.  MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.

Authors:  Ruifang Wu; Jinrong Zeng; Jin Yuan; Xinjie Deng; Yi Huang; Lina Chen; Peng Zhang; Huan Feng; Zixin Liu; Zijun Wang; Xiaofei Gao; Haijing Wu; Honglin Wang; Yuwen Su; Ming Zhao; Qianjin Lu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 8.  At the crossroads of gout and psoriatic arthritis: "psout".

Authors:  Renaud Felten; Pierre-Marie Duret; Jacques-Eric Gottenberg; Lionel Spielmann; Laurent Messer
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

9.  GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.

Authors:  Xichun Xia; Guangchao Cao; Guodong Sun; Leqing Zhu; Yixia Tian; Yueqi Song; Chengbin Guo; Xiao Wang; Jingxiang Zhong; Wei Zhou; Peng Li; Hua Zhang; Jianlei Hao; Zhizhong Li; Liehua Deng; Zhinan Yin; Yunfei Gao
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

10.  Toll-like receptors and antimicrobial peptides expressions of psoriasis: correlation with serum vitamin D level.

Authors:  Sue Kyung Kim; Sun Park; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.